ReviewCurrent infectious disease reports2020
COVID-19 in the Pediatric Population-Review and Current Evidence.
Review in Current infectious disease reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 49 citations in OpenAlex.
- COVID-19 in patients with Down syndrome: A systematic review.Immunity, inflammation and disease · 2024Pooled it
- Critical analysis of acute kidney injury in pediatric COVID-19 patients in the intensive care unit.Pediatric nephrology (Berlin, Germany) · 2021Pooled it
- Back to school: The effect of school visits during COVID-19 on COVID-19 outcomes.Journal of health economics · 2025Article
- Pediatric Intensive Care Nurse Staffing Measures and Patient Outcomes During the COVID-19 Pandemic.JAMA network open · 2025Observational
- Hematological profile, inflammatory markers and serum liver enzymes in COVID 19 positive children vs. COVID 19 negative ones-a comparative study.Frontiers in pediatrics · 2024Article
- Metabolomics in pediatric lower respiratory tract infections and sepsis: a literature review.Pediatric research · 2023Review
- The deadly impact of COVID-19 among children from Latin America: The case of Ecuador.Frontiers in pediatrics · 2023Article
- Longitudinal Household Assessment of Respiratory Illness in Children and Parents During the COVID-19 Pandemic.JAMA network open · 2022Article
- Narrative Review: Addressing Covid-19 Vaccine Concerns in Special and Vulnerable Populations.Hospital pharmacy · 2022Article
- COVID-19 in a tertiary paediatric centre in Portugal: a single-centre retrospective study.BMJ paediatrics open · 2022Article
- Epidemiological, virological and clinical features of SARS-CoV-2 among individuals during the first wave in Cameroon: Baseline analysis for the EDCTP PERFECT-Study RIA2020EF-3000.Journal of public health in Africa · 2022Article
- Clinical Factors Associated with COVID-19 Severity in Chronic Hospitalized Infants and Toddlers: Data from a Center in the West Part of Romania.Healthcare (Basel, Switzerland) · 2022Article
- Risk Behaviors, Family Support, and Emotional Health among Adolescents during the COVID-19 Pandemic in Israel.International journal of environmental research and public health · 2022Article
- Anxiety in Paediatric Patients Diagnosed with COVID-19 and the Affecting Factors.Journal of tropical pediatrics · 2022Article
- Immunological features of the multisystem inflammatory syndrome associated with SARS-CoV-2 in children.American journal of clinical and experimental immunology · 2022Review
- Severe Thrombocytopenic Purpura Associated with COVID-19 in a Pediatric Patient.Infection and drug resistance · 2022Article
- Acute Neurological Presentation in Children With SARS-CoV-2 Infection.Frontiers in pediatrics · 2022Article
- Impact of the COVID-19 Pandemic on Patient- and Family-Centered Care and on the Mental Health of Health Care Workers, Patients, and Families.Frontiers in pediatrics · 2022Review
- SARS-CoV-2 Positivity in Early Infancy: A National Cohort From Saudi Arabia.Frontiers in pediatrics · 2022Article
- Severe hypertriglyceridemia: A rare complication of diabetic ketoacidosis in a 3-year-old with SARS-CoV-2 infection.Journal of clinical and translational endocrinology case reports · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewCoronavirus disease 2019 (COVID-19) pandemic has major health and economic impacts. We review disease characteristics in children. RECENT
findingsChildren comprise 1-2% of the diagnosed cases, and typically suffer mild disease. The median age of infected children is 3.3-11 years, and male/female ratio is 1.15-1.55. Common symptoms in children include upper respiratory symptoms (26-54%), cough (44-54%), fever (32-65%), and gastrointestinal (15-30%) symptoms. Substantial proportion (4-23%) are asymptomatic. Death rates are up to 0.7%. Risk factors associated with severe disease are neonatal age group, male gender, lower respiratory tract disease, and pre-existing medical conditions. Vertical transmission was reported. Multisystem inflammatory syndrome (MIS), characterized by fever, multisystem organ involvement, and laboratory markers of inflammation, causes critical illness in > 50% of cases and is increasingly reported from endemic countries. Indirect effects of the coronavirus epidemic include higher rates of psychiatric morbidities, education loss, unhealthy lifestyle changes, and increased child neglect. Vaccines are in clinical trials and immunogenicity has not yet been shown in children. SUMMARY: Overall, COVID-19 has lower incidence and causes milder disease in children compared with adult patients. MIS is a rare severe complication more common in children. More data on the efficacy and safety of antivirals in children are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.